• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗玫瑰痤疮中减少炎症性皮损计数的疗效:系统评价。

Efficacy of Treatments in Reducing Inflammatory Lesion Count in Rosacea: A Systematic Review.

机构信息

Temerty School of Medicine, University of Toronto, Toronto, ON, Canada.

Dalla Lana School of Public Health and Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

J Cutan Med Surg. 2024 Jul-Aug;28(4):352-359. doi: 10.1177/12034754241253195. Epub 2024 May 28.

DOI:10.1177/12034754241253195
PMID:38807451
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11408985/
Abstract

INTRODUCTION

Rosacea is a chronic inflammatory skin condition affecting approximately 5.5% of the global population. Patients present heterogeneously with a mix of features in the central facial region, of which papules and pustules are considered to be a major feature. The identification of effective treatments for reducing inflammatory lesions in rosacea can alleviate the psychosocial burden that many rosacea patients experience, including reduced self-esteem, anxiety, and social withdrawal. The objective of this systematic review is to determine the effectiveness of topical and systemic therapies in reducing lesion count in rosacea patients.

METHODS/RESULTS: Medline, Embase, and Cochrane CENTRAL databases were searched, resulting in the inclusion of 43 clinical trials reporting on a total of 18,347 rosacea patients. The most well-studied treatments include ivermectin, metronidazole, azelaic acid, minocycline, and doxycycline. Oral isotretinoin was the most effective treatment in reducing inflammatory lesions and may be recommended for severe recalcitrant cases of rosacea.

CONCLUSIONS

Several topical and systemic therapies have demonstrated efficacy in reducing inflammatory lesion count in rosacea patients, with mechanisms of action centred around suppressing inflammation and killing mites. Additional research is required to determine effective combination therapies in rosacea.

摘要

简介

酒渣鼻是一种影响全球约 5.5%人口的慢性炎症性皮肤疾病。患者在面部中央区域表现出异质性,伴有多种特征,其中丘疹和脓疱被认为是主要特征。寻找减少酒渣鼻炎症病变的有效治疗方法可以减轻许多酒渣鼻患者所经历的心理社会负担,包括自尊心下降、焦虑和社交退缩。本系统评价的目的是确定局部和全身治疗在减少酒渣鼻患者病变计数方面的有效性。

方法/结果:检索了 Medline、Embase 和 Cochrane CENTRAL 数据库,共纳入了 43 项临床试验,总计纳入了 18347 例酒渣鼻患者。研究最多的治疗方法包括伊维菌素、甲硝唑、壬二酸、米诺环素和多西环素。口服异维 A 酸是减少炎症病变最有效的治疗方法,可能推荐用于严重难治性酒渣鼻病例。

结论

几种局部和全身治疗方法已被证明在减少酒渣鼻患者的炎症病变计数方面有效,其作用机制主要集中在抑制炎症和杀死螨虫上。需要进一步研究以确定酒渣鼻的有效联合治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/11408985/0f1428b7829a/10.1177_12034754241253195-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/11408985/ee9a517ca5fc/10.1177_12034754241253195-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/11408985/0f1428b7829a/10.1177_12034754241253195-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/11408985/ee9a517ca5fc/10.1177_12034754241253195-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37ed/11408985/0f1428b7829a/10.1177_12034754241253195-fig2.jpg

相似文献

1
Efficacy of Treatments in Reducing Inflammatory Lesion Count in Rosacea: A Systematic Review.治疗玫瑰痤疮中减少炎症性皮损计数的疗效:系统评价。
J Cutan Med Surg. 2024 Jul-Aug;28(4):352-359. doi: 10.1177/12034754241253195. Epub 2024 May 28.
2
Interventions for rosacea.酒渣鼻的干预措施。
Cochrane Database Syst Rev. 2015 Apr 28;2015(4):CD003262. doi: 10.1002/14651858.CD003262.pub5.
3
Interventions for rosacea.酒渣鼻的干预措施。
Cochrane Database Syst Rev. 2011 Mar 16(3):CD003262. doi: 10.1002/14651858.CD003262.pub4.
4
Interventions for rosacea.酒渣鼻的干预措施。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003262. doi: 10.1002/14651858.CD003262.pub3.
5
Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials.壬二酸治疗丘疹脓疱型玫瑰痤疮:随机对照试验的系统评价
Arch Dermatol. 2006 Aug;142(8):1047-52. doi: 10.1001/archderm.142.8.1047.
6
Interventions for rosacea.酒渣鼻的干预措施。
Cochrane Database Syst Rev. 2004(1):CD003262. doi: 10.1002/14651858.CD003262.pub2.
7
Effective and evidence-based management strategies for rosacea: summary of a Cochrane systematic review.有效且基于证据的酒渣鼻管理策略:Cochrane 系统评价综述。
Br J Dermatol. 2011 Oct;165(4):760-81. doi: 10.1111/j.1365-2133.2011.10473.x. Epub 2011 Sep 15.
8
Interventions for rosacea: abridged updated Cochrane systematic review including GRADE assessments.酒渣鼻治疗措施:简化更新后的 Cochrane 系统评价,包括 GRADE 评估。
Br J Dermatol. 2015 Sep;173(3):651-62. doi: 10.1111/bjd.13956. Epub 2015 Aug 30.
9
Efficacy of Treatments in Reducing Facial Erythema in Rosacea: A Systematic Review.治疗酒渣鼻面部红斑的疗效:一项系统评价
J Cutan Med Surg. 2025 Jan-Feb;29(1):43-50. doi: 10.1177/12034754241287546. Epub 2024 Oct 31.
10
Systematic review of rosacea treatments.酒渣鼻治疗的系统评价。
J Am Acad Dermatol. 2007 Jan;56(1):107-15. doi: 10.1016/j.jaad.2006.04.084. Epub 2006 Nov 7.

引用本文的文献

1
Rosacea in childhood and adolescence: A review.儿童和青少年酒渣鼻:综述
J Dtsch Dermatol Ges. 2025 Jun;23(6):684-691. doi: 10.1111/ddg.15693. Epub 2025 Mar 22.
2
Ocular Rosacea: An Updated Review.眼部酒渣鼻:最新综述
Cornea. 2025 Apr 1;44(4):525-537. doi: 10.1097/ICO.0000000000003785. Epub 2025 Jan 14.

本文引用的文献

1
Exploring the Pathogenesis and Mechanism-Targeted Treatments of Rosacea: Previous Understanding and Updates.探索酒渣鼻的发病机制及机制导向治疗:既往认识与更新
Biomedicines. 2023 Jul 31;11(8):2153. doi: 10.3390/biomedicines11082153.
2
First ex vivo cultivation of human Demodex mites and evaluation of different drugs on mite proliferation.首次人类毛囊蠕形螨的体外培养及其对不同药物对螨虫增殖影响的评价。
J Eur Acad Dermatol Venereol. 2022 Dec;36(12):2499-2503. doi: 10.1111/jdv.18468. Epub 2022 Aug 4.
3
Rosacea, an infectious disease: why rosacea with papulopustules should be considered a demodicosis. A narrative review.
酒渣鼻,一种传染病:为什么有丘疹脓疱的酒渣鼻应被视为蠕形螨病。一篇叙述性综述。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):987-1002. doi: 10.1111/jdv.18049. Epub 2022 Mar 31.
4
Minocycline Extended-Release Comparison with Doxycycline for the Treatment of Rosacea: A Randomized, Head-to-Head, Clinical Trial.米诺环素缓释剂与多西环素治疗酒渣鼻的比较:一项随机、直接比较的临床试验。
J Clin Aesthet Dermatol. 2021 Dec;14(12):16-23.
5
Metronidazole gel (0.75%) in Japanese patients with rosacea: A randomized, vehicle-controlled, phase 3 study.甲硝唑凝胶(0.75%)治疗日本酒渣鼻患者的随机、赋形剂对照、3 期研究。
J Dermatol. 2022 Mar;49(3):330-340. doi: 10.1111/1346-8138.16254. Epub 2021 Dec 1.
6
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
7
Open-label Extension Study Evaluating Long-term Safety and Efficacy of FMX103 1.5% Minocycline Topical Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea.评估FMX103 1.5%米诺环素外用泡沫治疗中度至重度丘疹脓疱型玫瑰痤疮的长期安全性和有效性的开放标签扩展研究。
J Clin Aesthet Dermatol. 2020 Nov;13(11):44-49. Epub 2020 Nov 1.
8
Vehicles for atopic dermatitis therapies: more than just a placebo.特应性皮炎治疗药物的载体:不仅仅是安慰剂。
J Dermatolog Treat. 2022 Mar;33(2):685-698. doi: 10.1080/09546634.2020.1789050. Epub 2020 Jul 16.
9
Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: A randomized clinical trial.局部使用伊维菌素-甲硝唑凝胶治疗蠕形螨引起的睑缘炎:一项随机临床试验。
Cont Lens Anterior Eye. 2021 Jun;44(3):101326. doi: 10.1016/j.clae.2020.04.011. Epub 2020 May 24.
10
Minocycline 1.5% foam for the topical treatment of moderate to severe papulopustular rosacea: Results of 2 phase 3, randomized, clinical trials.米诺环素 1.5%泡沫剂治疗中重度丘疹脓疱性酒渣鼻的疗效:两项 3 期随机临床试验结果。
J Am Acad Dermatol. 2020 May;82(5):1166-1173. doi: 10.1016/j.jaad.2020.01.043. Epub 2020 Jan 28.